Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

This study has been terminated.
(Early end of enrolment with regards to difficulty met to enrol patients despite previous protocol amendments.)
Sponsor:
Information provided by (Responsible Party):
Steba Biotech S.A.
ClinicalTrials.gov Identifier:
NCT00975039
First received: September 10, 2009
Last updated: July 4, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2012
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)